2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia.
Walewska R. et al, (2025), Br J Haematol, 207, 2296 - 2313
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology.
Domenico D. et al, (2025), Nat Commun, 16
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.
Munir T. et al, (2025), N Engl J Med, 393, 1177 - 1190
Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancer.
Zeisig BB. et al, (2025), Blood, 146, 1314 - 1330
Circulating tumour DNA to augment PET-CT in determining clinical outcome after head and neck cancer treatment.
Bola S. et al, (2025), Eur J Cancer, 227
Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer.
Ward JC. et al, (2025), J Pathol, 267, 40 - 55
Outcomes and Risk Factors for Complications of Dermis-Fat Graft as Primary Orbital Implant.
Schuh A. et al, (2025), Ophthalmic Plast Reconstr Surg
Diagnosing Burkitt Lymphoma in Sub-Saharan Africa by Sequencing of Circulating Tumor DNA: A Comparative Microcosting Study.
Morrell L. et al, (2025), Value Health Reg Issues, 48
Rituximab for children with EBV-positive Burkitt lymphoma in East Africa.
Mawalla WF. et al, (2025), Blood Adv, 9, 2393 - 2401
A Systematic Approach to Prioritise Diagnostically Useful Findings for Inclusion in Electronic Health Records as Discrete Data to Improve Clinical Artificial Intelligence Tools and Genomic Research.
Guillod P. et al, (2025), Clin Oncol (R Coll Radiol), 39
Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis.
Schoenpflug LA. et al, (2025), J Pathol, 265, 184 - 197
Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signals.
Vavoulis DV. et al, (2025), Nat Commun, 16
Artificial intelligence in breast cancer diagnosis: A systematic literature review.
Javaeed A. and Schuh A., (2025), Camb Prism Precis Med, 3
Ocular surface squamous cell neoplasia: risk factors for aggressive growth behaviour and the role of Ki-67
Schuh A. et al, (2025), Canadian Journal of Ophthalmology
Outcomes, challenges and prospects of emicizumab prophylaxis in Sub-Saharan Africa - Insights from the Tanzanian experience
Mwakichako RW. et al, (2025), Journal of Haemophilia Practice, 12, 15 - 22
Applications of Nanopore sequencing in precision cancer medicine.
Dyshlovoy SA. et al, (2024), Int J Cancer, 155, 2129 - 2140
Effect of Compression Dressing After Upper Eyelid Blepharoplasty on Edema, Ecchymosis, Pain, and Ocular Surface Irritation.
Schuh A. et al, (2024), Ophthalmic Plast Reconstr Surg, 40, 627 - 633
Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials.
Carr L. et al, (2024), Br J Haematol, 205, 2072 - 2076